Search clinical trials for: CEP-37250/KHK2804

Total 1649 results

Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin Pharma, Inc.; Teva Pharma

Completed

Phase 1 Study of CEP-37250/KHK2804 in Subjects With Advanced Solid Tumors

Adenocarcinoma of the Pancreas | Solid Tumour | Adenocarcinoma of the Colorectal
Cephalon

Terminated

Single Ascending-Dose Study to Characterize the Safety, Pharmacokinetics, and Pharmacodynamics of CEP-37251 in Healthy Postmenopausal Women

Osteoporosis | Bone Loss

Australia
Fondazione IRCCS Istituto Nazionale dei Tumori,...

Recruiting

Effects of Acute and Chronic Exercise on Myeloid-Derived Suppressor Cells in Melanoma Patients (Agility)

Melanoma

Italy
Rise Therapeutics LLC
University of Colorado, Denver; Mayo Clinic

Recruiting

R-3750 in Patients With Mild to Moderate Ulcerative Colitis

Ulcerative Colitis | Ulcerative Colitis Chronic Moderate | Ulcerative Colitis Chronic | Ulcerative Colitis Chronic Mild

United States
Cephalon

Completed

Study of the Efficacy, Safety and Tolerability of Oral CEP-701 in Patients With Severe Psoriasis

Psoriasis

United States
Cephalon

Completed

Open Study of CEP-701 in Patients With Refractory Acute Myeloid Leukemia With FLT-3 Mutation

Leukemia, Myeloid
Kyowa Kirin, Inc.

Terminated

Study of KHK2823 in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

Acute Myeloid Leukemia | Myelodysplastic Syndrome

United Kingdom
Cephalon
H. Lundbeck A/S; The Parkinson Study Group

Terminated

Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's Disease

Parkinson Disease

United States, Canada, Puerto Rico
Edwards Lifesciences

Completed

Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX

Coronary Artery Disease | Heart Failure | Aortic Valve Stenosis | Aortic Valve Insufficiency | Aortic Valve Disorder

Canada, United States, Austria, Germany, Spain, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

To Determine the Maximum Tolerated Dose of Oral CEP-37440 in Patients With Advanced or Metastatic Solid Tumors

Solid Tumors

United States
Cephalon, Inc.

Terminated

A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States, Belgium, Czechia, France, Germany, Hungary, Poland, Portugal, Spain, Ukraine, United Kingdom
Augusta University

Completed

Mechanism of Action of Biofeedback Therapy

Hypersensitivity | Constipation | Hyposensitivity

United States
Ronald Hoffman
National Cancer Institute (NCI); Myeloproliferative Disorders-Research Consortium

Unknown

CEP-701 (Lestaurtinib) in Myelofibrosis

Polycythemia Vera | Essential Thrombocythemia | Myelofibrosis

United States
Cephalon

Terminated

Efficacy and Safety of Oral CEP-701 for the Treatment of Patients With Advanced Multiple Myeloma

Myeloma

United States
Kyowa Kirin Co., Ltd.

Terminated

Phase 1 Study of KHK2898 in Subjects With Advanced Solid Tumors

Solid Tumour

Singapore
Emory University
National Institute on Aging (NIA)

Recruiting

PRogram to Improve Stress-levels and Enhance Memory (PRISEM)

Mild Cognitive Impairment

United States
University of Michigan Rogel Cancer Center

Recruiting

Multicenter Trial of ESK981 in Patients With Select Solid Tumors

Pancreatic Adenocarcinoma | Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Carcinoma | Adenosquamous Carcinoma | Gastrointestinal Neuroendocrine Tumor | Gastrointestinal Neuroendocrine Carcinoma | Neuroendocrine Prostate Carcinoma

United States
New Approaches to Neuroblastoma Therapy Consortium
National Cancer Institute (NCI)

Completed

N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma

Neuroblastoma

United States, Canada
University of Chicago
Patient-Centered Outcomes Research Institute

Recruiting

Comprehensive Care Community and Culture Study

Comprehensive Care | Quality of Care | Medicare | Cost of Care

United States
Cephalon

Completed

Open-Label Study to Determine the Maximum Tolerated Oral Dose of the Kinase Inhibitor CEP-11981 in Patients With Advanced Cancer

Cancer
Cephalon, Inc.

Completed

A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)

Systemic Lupus Erythematosus

United States, Belgium, Czechia, France, Germany, Hungary, Poland, Portugal, Spain, Ukraine, United Kingdom
Cephalon

Completed

Study of CEP-701 in Treatment of Prostate Cancer

Prostate Cancer

United States
Edwards Lifesciences

Completed

Magna Mitral - 23mm

Mitral Heart Valve Disease

United States, Poland
Cephalon

Completed

Study of CEP-9722 as Single-Agent Therapy and as Combination Therapy With Temozolomide in Patients With Advanced Solid Tumors

Solid Tumor

France, United Kingdom
Cephalon

Completed

Study to Evaluate the Safety and Efficacy of Placulumab (CEP-37247) Administered by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk Herniation

Sciatica

United States, Australia
M.D. Anderson Cancer Center
Cephalon

Completed

CEP-701 for PH-negative Myelofibrosis

Leukemia | Myelofibrosis

United States
University of California, San Francisco
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Recruiting

Effectiveness and Acceptability of Insertable Devices for Obstetric Fistula Management (COPE)

Fistula | Obstetric Fistula | Fistula, Urinary | Fistula, Vaginal

Ghana
Oslo University Hospital
University of Oslo

Completed

Vitamin E Polyethylene in Semented Cups (E1vsMar)

Total Hip Arthroplasty (THA)

Norway
Sahlgrenska University Hospital, Sweden

Completed

Investigating Proximal Migration in Trabecular Metal Cups Used In Acetabular Revision Surgery

Prosthesis Loosening

Sweden
Centre for Interdisciplinary Research in Rehabilitation...
Fonds de la Recherche en Santé du Québec

Completed

Effectiveness of Multimodal Cognitive Rehabilitation for Traumatic Brain Injury Sustained During Older Adulthood

TBI (Traumatic Brain Injury) | Aging | Rehabilitation

Canada
University of Miami

Completed

Preventing Adolescents From Entering the Juvenile Justice System (CCP)

Substance Use | Delinquency

United States
3M
Eurotrials Brasil Consultores Cientificos Ltda

Completed

Passive Disinfection Cap Compliance Study

Infection, Hospital

United States
University of Guelph
Agriculture and Agri-Food Canada; Saskatchewan Pulse Growers

Completed

Various Serving Sizes of Lentils on Blood Glucose and Insulin

Healthy

Canada
Uppsala University
The Swedish Research Council

Recruiting

Dual Mobility Cups in Hip Fracture Patients (DUALITY)

Femoral Neck Fractures

Sweden
Suzhou Connect Biopharmaceuticals, Ltd.

Active, not recruiting

A Study to Evaluate the Safety and Efficacy of CBP-201 in Chinese Adult Subjects With Moderate to Severe AD

Atopic Dermatitis

China
DePuy Orthopaedics

Completed

Clinical Study Evaluating an Acetabular Cup System After Total Hip Replacement

Arthritis | Osteoarthritis | Rheumatoid Arthritis | Avascular Necrosis | Acute Fracture

United States
Medical University of South Carolina

Completed

Assessing the Effectiveness and Safety of the ID-Cap System for Medication Monitoring and Adherence

Medication Adherence

United States
Ascendis Pharma Growth Disorders A/S

Active, not recruiting

A Clinical Trial to Evaluate Efficacy and Safety of TransCon CNP Compared With Placebo in Children With Achondroplasia (ApproaCH)

Achondroplasia

United States, Denmark, Ireland, New Zealand, Australia, Canada, Spain
Ascendis Pharma A/S

Active, not recruiting

A Dose Escalation Trial Evaluating Safety, Efficacy, and Pharmacokinetics of TransCon CNP Administered Once Weekly in Prepubertal Children With Achondroplasia

Achondroplasia

United States, Australia, Austria, Denmark, Germany, Ireland, New Zealand, Portugal
Concert Pharmaceuticals

Completed

Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata

Alopecia Areata

United States
Concert Pharmaceuticals

Completed

Study to Evaluate the Safety and Efficacy of CTP-543 in Adults With Moderate to Severe Alopecia Areata

Alopecia Areata

United States
Dalhousie University

Completed

Radiostereometric Analysis (RSA) and DEXA to Evaluate Fixation and Wear of the Restoration ADM Acetabular System

Osteoarthritis

Canada
Concert Pharmaceuticals

Completed

Multiple Ascending Dose Study in Healthy Volunteers

Healthy

Australia
Northern Orthopaedic Division, Denmark

Not yet recruiting

Dual Mobility Cup Versus Unipolar Cup

Dislocation, Hip

Denmark
Wyndhurst Counseling Center
Liberty University

Completed

Use of Alpha-Stim Cranial-electrotherapy Stimulation (CES) in the Treatment of Anxiety

Anxiety

United States
JointResearch

Recruiting

Dual-mobility Cups Compared to Unipolar Cups on Dislocation and Cost-effectiveness After Primary Total Hip Arthroplasty. (REDEP)

Osteoarthritis, Hip | Total Hip Arthroplasty

Netherlands
University of Aarhus
Zimmer Biomet

Completed

Evaluation of Cemented and Cementless Fixation of Dual-mobility Hip Prosthesis in Elderly Patients With Osteoarthritis

Osteoarthritis, Hip | Arthropathy of Hip

Denmark
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Unknown

ESK981 and Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration Levels of Testosterone | Prostate Carcinoma Metastatic in the Bone

United States
Edwards Lifesciences

Active, not recruiting

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Coronary Artery Disease | Heart Failure | Mitral Valve Regurgitation | Mitral Valve Incompetence

Canada, United States, Austria, Germany
Coherent Biopharma (Hefei) Co., Ltd.

Recruiting

A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors

Cancer, Breast | Cancer of Pancreas | Cancer Colorectal | Cancer, Lung | Cancer of Esophagus

China, United States

Search clinical trials for: CEP-37250/KHK2804

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations